Impact of MAFLD on HBV-Related Stage 0/A Hepatocellular Carcinoma after Curative Resection.
Yen-Po LinShu-Hsien LinChih-Chi WangChih-Che LinDing-Wei ChenChing-Hui ChuangPao-Yuan HuangChao-Hung HungShih-Yu YangWei-Ru ChoYu-Syuan ChenMing-Chao TsaiPublished in: Journal of personalized medicine (2021)
The overall prognosis in HBV-related early-stage HCC, in terms of HCC recurrence and death or liver transplantation, was not significantly different between patients with and without MAFLD. Among patients with MALFD, lean-MAFLD was a risk factor for HCC recurrence. Further studies are warranted to validate these results.